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Summary Nine primary pulmonary carcinomas, one metastatic carcinoma, and two malignant pleural
mesotheliomas have been analysed for the expression at the mRNA level of metalloproteinases (MPs) and
tissue inhibitors of MPs (TIMPs). In situ hybridisation showed TIMP-1 and TIMP-2 transcripts predominantly
over tumour stroma and gelatinases evenly distributed over both stromal and tumour cells. While both
TIMP-1 and TIMP-2 were expressed in non-neoplastic lungs (NNL) as well as in carcinomas, stromelysin 3
(ST3), 92 kDa gelatinase and interstitial collagenase were expressed only by carcinomas. Expression of these
MPs by carcinomas was independent of histologic type and such tumour features as fibrosis or necrosis. The
consistent expression of ST3 by all of the carcinomas examined and absence ofits expression in NNL indicates
that ST3 production is likely associated with the malignant phenotype. However, since 92 kDa gelatinase and
interstitial collagenase transcripts were found in some but not all tumour samples, their expression is not a
uniform feature of pulmonary carcinomas. The possible prognostic significance of the expression of the latter
two enzymes by carcinomas remains to be established.
Turnover of the extracellular matrix (ECM) takes place rela-
tively slowly in mature tissues but the pace is greatly
accelerated during the tissue remodelling that accompanies
processes such as inflammation or malignancy. Matrix degra-
dation is a tightly regulated process in which secreted
enzymes of the metalloproteinase (MP) family play key roles
(Murphy & Reynolds, 1985; Matrisian, 1991; Birkedal-Han-
sen et al., 1992). MPs are Zn-dependent proteinases which
include interstitial (or specific) collagenase, gelatinases (type
IV collagenases), stromelysins (or proteoglycanases) and
PUMP-1 (originally, putative metalloproteinase-1) (Whitham
et al., 1986; Collier et al., 1988; Muller et al., 1988; Quantin
et al., 1989; Wilhelm et al., 1989; Brown et al., 1990). These
enzymes display characteristic substrate specificities and in
combination they are able to destroy all the constituent
proteins of the ECM (Murphy & Reynolds, 1985; Collier et
al., 1988; Matrisian, 1991). The function of MPs is regulated
at several levels. Transcription of some members of the
family is strongly influenced by cytokines and inflammatory
mediators (Saklatvala, 1985; Stetler-Stevenson et al., 1990;
Circola et al., 1991). Moreover, MPs are released from cells
as inactive proenzymes that have to be activated by pro-
teolysis, often by serine proteinases that function in a 'cas-
cade' mechanism (Murphy & Reynolds, 1985; Matrisian,
1991; Birkedal-Hansen et al., 1992). When activated their
enzymatic activity is controlled by specific tissue inhibitors
(TIMPs). Two TIMPs (TIMP-1 and TIMP-2) have been
described both of which have similar activities against the
major MPs (Murphy & Reynolds, 1985; Goldberg et al.,
1989; Stetler-Stevenson et al., 1989; Boone et al., 1990; Mat-
risian, 1991; Birkedal-Hansen et al., 1992). Considerable
evidence supports the notion that the balance between the
levels of extracellular MPs and TIMPs is the primary deter-
minant of the rate of ECM turnover.
The purpose of this study was to investigate the patterns of
expression of major MPs and TIMPs in primary lung carcin-
omas. Correlation of such results with data obtained from
non-neoplastic lung tissue (NNL) will identify those MPs
which may play significant roles in the pathophysiology of
pulmonary carcinomas. It will also help to focus future
research on possible associations between these ECM-regu-
lating functions and other factors such as cytokines, the
interplay between which may have important consequences
for the processes of invasion and metastasis.
Materials and methods
Source oftissue
The tissue was obtained from 10 lungs resected for carcin-
omas (nine cases of primary carcinomas, one of metastatic
colonic carcinoma) and two cases of malignant pleural meso-
theliomas. These originated from five women and seven men.
Lung resections were received fresh in the Department of
Pathology where appropriate sections were taken for RNA
extraction, quick frozen in liquid nitrogen and then stored at
- 70°C. In each case tissue was taken from two aspects of the
tumour, one underneath the pleura and one from the oppo-
site aspect (medial). Samples of non-neoplastic lung were
taken from sites away from the tumour as controls. The
sections of areas taken as controls were examined histo-
logically in order to eliminate tissue which would contain
endogenous pneumonia or fibrosis. An additional section of
tumour was frozen in liquid nitrogen in OCT-medium and
stored at -70'C for subsequent in situ hybridisation studies.
DNA probes
Full-length human TIMP-1 and human interstitial collagen-
ase cDNA probes were described previously (Edwards et al.,
1987; Kossakowska et al., 1991). The TIMP-2 full length
human gene was isolated by polymerase chain reaction
(PCR) amplification from cDNA prepared from human
MRC5 fetal lung fibroblasts. The PCR product was gener-
ated using oligonucleotides that introduced Sma I and Stu I
sites 5' and 3' of the coding region, giving rise to a 680 bp
fragment containing the entire human TIMP-2 coding region
(Boone et al., 1990). After digestion with Sma I and Stu I,
the PCR product was cloned into EcoRV cut pBluescriptIl
KS and its identity was confirmed by DNA sequence ana-
lysis.
The 72 kDa type IV collagenase was a 210 bp fragment of
C-terminal and 3'-non-coding sequences kindly provided by
Dr A. Docherty (Celltech, UK), and was also described
previously (Kossakowska et al., 1991). The 92 kDa type IV
Correspondence: Dr S.J. Urbanski, Department of Histopathology,
Foothills Hospital, 1403-29th Street N.W., Calgary, Alberta T2N
2T9, Canada.
Received 26 February 1992; and in revised from 27 July 1992.
Br. J. Cancer (1992), 66, 1188-1194 '." Macmillan Press Ltd., 1992MATRIX METALLOPROTEINASES AND TIMPs 1189
collagenase probe was a donation from Dr G. Goldberg,
Division of Dermatology, Washington University School of
Medicine, St. Louis, Missouri, USA (Wilhelm et al., 1989).
The stromelysin-3 cDNA probe was a generous gift from Dr
P. Chambon, Laboratoire de Genetique Moleculare des
Eukaryotes du CNRS, Strasbourg Cedex, France (Basset et
al., 1990), and PUMP-1 was obtained from Dr L. Matrisian,
Vanderbilt University Medical School, Nashville, Tennesse
(Matrisian, 1991).
RNA isolation andnorthern blot analysis
Total cellular RNA was extracted from lung tissue homogen-
ised in guanidinium isothiocyanate and centrifuged through
cesium chloride gradients as previously described (Kossakow-
ska et al., 1991). Total cellular RNA (10 g) from each case
was electrophoresed in formaldehyde containing 1.1% agar-
ose gels, transferred to HYBOND-N membranes (Amer-
sham) in 20 x SSC buffer and fixed by baking at 80°C for
2 h. The blots were probed with nick-translated 32P-labelled
DNA probes (specific activity> 108 c.p.m.fig-') and auto-
radiographed using Kodak XAR-5 film (Eastman Kodak,
Rochester, NY). Subsequently, blots were reprobed with a
murine 18S rRNA probe or stained with methylene blue to
confirm equivalence of loading. Comparisons between differ-
ent blots were made possible by the inclusion of two com-
mon samples on each.
RNA probepreparation and in situ hybridisation
Sense and anti-sense 35S-RNA probes were prepared from
human TIMP-1, TIMP-2, 72 kDa gelatinase and 92 kDa
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gelatinase cDNAs cloned in either pBluescript KS- (Stra-
tagene) or pGEM2 (Promega) vectors. Details of the TIMP-l
probes have been described previously (Kossakowska et al.,
1991). For TIMP-2 in pBluescript KS-, sense probes were
generated by T3 polymerase following digestion with EcoRI,
and anti-sense probes were made by T7 polymerase after
HindlII digestion of template. The sense and anti-sense
72kDa gelatinase probes were produced from template
digested with BamHI and XbaI, using T7 and T3 polymer-
ases, respectively. For in situ studies a fragment of 92 kDa
gelatinase from the 5' end of the cDNA to a BamHI site at
nucleotide 390 (Wilhelm et al., 1989) was subcloned into
pBluescript KS-, and sense and anti-sense probes were made
from NotI and EcoRV restricted templates, with T3 and T7
polymerases, respectively.
For in situ hybridisation 2-3tim thick cryostat sections
were placed on glass slides coated with 2% aminopropyl-
triethoxysilane and fixed with 4% para-formaldehyde. After
rehydration the sections were washed in 4 x SSC prior to
acetylation and pre-hybridisation in 4 x SSPE (Sambrook et
al., 1989), 1 x Denhardt's solution, and 50% deionised for-
mamide, 20mM dithiothreitol and 40 lgml-l E. coli tRNA
at 50°C for 3 h. The labelled riboprobes were diluted in the
prehybridisation mixture at a concentration of 3-5 ng of
RNA (1-2 x 10 c.p.m.) per 20 lI aliquot per slide. The
hybridisation was carried out at 50°C for 18 h. The slides
were then processed through the following stringency washes:
2 x SSC at room temperature, 2 x SSC at 50°C, RNase A
(4gg ml-) treatment for 30min at 37°C, 2 x SSC at 50°C.
Following dehydration through ethanol series the slides were
air dried and dipped in Kodak NTB-2 photographic emul-
sion diluted 1:1 with distilled water. After 2-4 weeks
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Figure 1 Stromelysin-3, TIMP-1, and TIMP-2 expression in lung carcinomas, adjacent non-neoplastic lung tissue, and meso-
thelioma. All lanes contained total cellular RNA (10pg) derived from the following cases (as in Table I): lanes I to 5, case 9; lane
6, mesothelioma; lanes 7 and 8, case 5; lane 9 and 10, case 8, lane I1, case 2; lanes 12 and 13, case 1. The upper panel represents
the blot hybridised with 32P nick-translated stromelysin-3 DNA probe, the middle panels show the same blot rehybridised with
TIMP-1 and TIMP-2 DNA probes and the lowest panel shows loading control hybridisation with 18S rRNA. These autoradiog-
raphs were obtained after 48 h exposure at -70C with an intensifying screen. The blot hybridised with 18S rRNA was exposed for
24 h at room temperature without the intensifying screen. Tissue origins are indicated as: TUP, tumour-pleural; TUM, tumour-
medial; L, non-neoplastic lung; PL, uninvolved pleura; M, mesothelioma.1190 S.J. URBANSKI et al.
exposure at 4°C the slides were developed in Dektol (East-
man Kodak Co.) and counterstained with haematoxylin and
eosin.
Results
Northern blot analysis was carried out to establish the ex-
pression patterns of the 72 kDa and 92 kDa gelatinases,
interstitial collagenase, stromelysin 3, PUMP-1, and TIMPs-I
and -2 in the nine primary lung carcinomas, one metastatic
colonic carcinoma to lung, two mesotheliomas, and NNL
(including uninvolved pleura). The NNL included seven cases
of morphologically normal lung adjacent to carcinomas.
Representative data are shown in Figures 1 and 2, and the
results are summarised in Table I.
For some of the genes under study, striking differences in
expression patterns between RNA isolated from carcinomas
and NNL were observed. Transcripts corresponding to ST3,
92 kDa gelatinase and interstitial collagenase were found
only in tumour samples, but not in NNL. For ST3, RNA
levels were low in all but two primary adenocarcinomas,
where strong signals were obtained from samples from the
pleural tumour aspect. Metastatic colonic adenocarcinoma
and mesotheliomas also expressed ST3 RNA. In the case of
92 kDa gelatinase, it was apparent that it was not always
expressed in the same tumours as ST3, or in the same
locations (i.e. medial vs pleural). Transcripts for 92 kDa
gelatinase were present in five primary and one metastatic
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carcinoma while no signal was seen in the remaining four
tumours. In most of the five positive cases, the signals were
relatively low with no appreciable difference in levels between
pleural and medial tumour aspects, except in the case of the
metastatic colonic carcinoma in which transcripts were not
detected in the medial aspect. Interstitial collagenase RNA
transcripts were detected in three out of nine carcinomas
analysed.
The RNAs coding for TIMP-1 and TIMP-2, 72 kDa gela-
tinase and PUMP-1 were present in malignant samples as
well as NNL. Our experiences with many Northern blots
suggest that TIMP-1 is the most highly expressed ofall ofthe
genes that we have analysed but its expression is variable and
generally higher in tumour vs non-neoplastic lung samples
(Figure 1). As reported previously, we observed two major
classes of TIMP-2 transcripts of 3.5 kb and 1.0 kb sizes, with
an additional minor 2.5 kb form in most tissues (Figure 1)
(Leco et al., 1992; Stetler-Stevenson et al., 1990). In almost
all cases the 3.5 kb species was the most abundant with the
1.0 kb form being barely visible for some tumour RNAs, as
has been seen previously in RNAs extracted from colorectal
tumours (Stetler-Stevenson et al., 1990).
Two additional points are apparent from inspection of the
data presented in Table I and Figures 1 and 2. Firstly, both
malignant pleural mesotheliomas studied showed no expres-
sion of 72 kDa and 92 kDa gelatinases and PUMP-1, where-
as the majority of carcinomas expressed these genes.
Secondly, all analysed adenocarcinomas exhibited some
degree of fibrosis, while necrosis was more prominent in
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Figure 2 Expression of RNAs encoding 72 kDa and 92 kDa gelatinases, interstitial collagenase and PUMP-I in human lung
carcinomas, adjacent non-neoplastic lung tissue, and mesotheliomas. All lanes contained total cellular RNA (10tsg) derived from
the following cases (as in Table I): lane 1, mesothelioma (the same case as lane 6 from Figure 1); lanes 2 and 3, case 9; lanes 4 to 7,
case 2; lane 8, second mesothelioma; lanes 9 to 12, case 8. The upper panels represent Northern blots hybridised with 72 kDa and
92 kDa gelatinases, interstitial collagenase and PUMP-1 32P nick-translated DNA probes and the lowest panel displays the same
blot rehybridised with 18S rRNA probe (loading control). The hybridised blots have been exposed for 48 h at - 70°C with an
intensifying screen. The blot hybridised with 18S rRNA was exposed for 24 h at room temperature without the intensifying screen.MATRIX METALLOPROTEINASES AND TIMPs 1191
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Figure 3 In situ hybridisation of squamous cell carcinoma with TIMP-1 (Al) and TIMP-2 (Bi) 35S rUTP-labelled anti-sense RNA
probes demonstrated signal predominantly over tumour stromal cells in both instances. A2 and B2 represent corresponding sense
controls (H&E counterstain x 160).
squamous cell carcinomas. However, neither of these morph-
ologic parameters showed a consistent association with the
expression patterns of particular MPs or TIMPs.
We carried out in situ hybridisation to tumour sections in
order to localise transcripts corresponding to TIMP-1,
TIMP-2, 72 kDa, and 92 kDa gelatinases. Differences in the
sites of expression of MPs and TIMPs were apparent, with
anti-sense TIMP-1 and TIMP-2 probes generating signals
predominantly over stromal elements (Figure 3, Al and Bi),
whereas anti-sense probes for both of the gelatinases resulted
in signals that were evenly distributed over both tumour and
stromal cells (Figure 4, Cl and Dl). Control sense-strand
RNA probes demonstrated that the signals observed were
specific (Figures 3 and 4, A2, B2, C2, D2); in addition,
pre-treatment with RNase A (4tLgml-') eliminated the
hybridisation obtained with all of the anti-sense RNA probes
(data not shown).
Discussion
We undertook the studies reported here in order to determine
whether different histologic types of lung carcinomas showed
characteristic patterns of expression of matrix remodelling
enzymes and inhibitors that have been linked with tumour
cell invasion. Moreover, we wished to know whether invasion
in vivo on the medial and pleural fronts of carcinomas might
represent specific remodelling phenomena that call for local-
ised production of particular degradative enzymes. Our data
reveal that certain MPs are frequently observed to be ex-
pressed at elevated levels in carcinomas, but expression of
none of the genes analysed to date could be correlated with a
particular tumour type or part of tumour (medial vs pleural).
Based on the analysis of a collection of nine primary
pulmonary carcinomas, we have detected not only differences
in the expression of MPs between carcinomas and NNL but
also heterogeneity in the expression of MPs among the
tumours. Expression of three MPs - ST3, 92 kDa gelatinase,
and interstitial collagenase - was detected in carcinomas but
not in NNL. ST3 was previously observed in 30 breast
carcinomas but only in low levels in one of five fibroaden-
omas (Basset et al., 1990). Detection of the same pattern of
expression in lung carcinomas supports the notion that ST3
represents an enzyme that is principally associated with the
malignant phenotype. ST3 expression characterises not only
primary carcinomas as it was also detected in pulmonary
metastases from colonic carcinoma. It has been also pre-
viously noted that 92 kDa gelatinase RNA was seen primari-
ly in breast carcinomas but not in fibroadenomas (Basset et
al., 1990). However, not all breast carcinomas expressed this
proteinase (Basset et al., 1990), and we demonstrate that this
situation also holds for human lungs where 92 kDa gelatinase
was expressed exclusively by carcinomas but only in five out
ofeight analysed primary tumours. Metastatic colonic adeno-
carcinoma also contained 92 kDa gelatinase RNAs. In situ
hybridisation revealed that 92 kDa gelatinase transcripts were
evenly distributed between stromal and tumour cells. Histio-
cytes, which are known to produce 92 kDa gelatinase (Wil-
helm et al., 1989), were not abundant in the tumour sections,
indicating that the total contribution of these cells to the
levels of 92 kDa gelatinase transcripts in lung carcinomas
must be small.
The third MP whose expression was linked to the malig-
nant phenotype was interstitial collagenase, transcripts for
which were seen in three out of eight carcinomas, but not in
the metastatic carcinomas or in any sample of NNL. Inspec-MATRIX METALLOPROTEINASES AND TIMPs 1193
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Figure 4 In situ hybridisation of squamous cell carcinoma with IIS-labelled anti-sense RNA probe corresonding to 72 kDa (ClI)
and 92 kDa (Dl) gelatinases demonstrated signal over tumour cells and stromal cells in both instances. C2 and D2 represent
corresponding sense controls (H&E counterstain x 160).
tion of Table I shows however, that 92 kDa gelatinase, inter-
stitial collagenase and ST3 are expressed independently of
each other and that their patterns of expression are not
influenced by or linked with such tumour features as the
amount of fibrosis or necrosis.
Both TIMP genes and PUMP-1 were expressed in all
normal and malignant tissue samples analysed. The TIMP-2
signal, which is largely attributable to the 3.5 kb RNA, was
relatively constant in both neoplastic and non-neoplastic lung
samples. In agreement with previous studies (Stetler-Steven-
son et al., 1990; Kossakowska et al., 1991), our data demon-
strate that TIMP-1 is expressed predominantly by host
stromal cells with transcript levels being elevated in some of
the tumour samples, possibly indicating the influence of
tumour-derived diffusible factors. Our data are the first to
demonstrate spatially-restricted TIMP-2 expression to
stromal elements in tumour. These findings support the idea
that the TIMPs may play a role in human neoplasia due to
their abilities to inhibit the active forms of MPs (DeClerck et
al., 1991).
In summary, our conclusions are:
1. Stromelysin 3 is consistently found to be expressed in
carcinomas but not in non-neoplastic lung tissue.
2. 92 kDa gelatinase and interstitial collagenase transcripts
are also absent from NNL and are present in some but
not all carcinomas.
3. Transcripts for 92 kDa and 72 kDa gelatinases are pre-
sent in both tumour and stromal cells, whereas TIMP-1
and TIMP-2 RNAs are principally localised to host
stroma.
This study extends to pulmonary carcinoma the associa-
tion between expression of ST3 and malignancy that had
been made from investigations of breast carcinoma (Basset et
al., 1990). It also indicates that 92 kDa gelatinase and inter-
stitial collagenase may play important roles in the biology of
certain carcinomas. More cases will be anlaysed and followed
for an adequate period of time in order to establish any
prognostic significance ofexpression of these two proteinases.
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